Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose phenylephrine and cyclopentolate for neonatal pupil dilation during retinopathy of prematurity screening
ACTRN12616001266459Phase 4Completed
- Sponsor
- University of Otago
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phenylephrine and cyclopentolate in retinopathy of prematurity (ROP) (2 arms), sponsored by University of Otago. Started Jan 2017; status: completed.
02
Drugs
phenylephrinecyclopentolate
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on ACTRN12616001266459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001266459.